Andrew A Renshaw

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Topics

Renal Cell Carcinoma

Prostate Cancer

Fine Needle Aspiration

Top Venues

Cancer cytopathology

Diagnostic cytopathology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah J Wu, Andrew A Renshaw, Peter M Sadow, Navin R Mahadevan, Michelle S Hirsch, Murugesan Manoharan, Edmund S Cibas
Cytologic diagnosis of papillary renal neoplasm with reverse polarity. Cancer cytopathology (2024)
Andrew A Renshaw, Martha B Pitman
Diagnostic terminology for benign/low-risk tumors on renal cytology. Cancer cytopathology (2023)
Andrew A Renshaw, Merce Jorda, Eva M Wojcik, Martha B Pitman
Low-risk oncocytic renal neoplasm: A useful cytologic diagnosis. Cancer cytopathology (2023)
Andrew A Renshaw, Martha B Pitman
Risk of malignancy in renal biopsy: A review. Cancer cytopathology (2023)
Andrew A Renshaw
The diagnosis of benign renal tumors on limited material. Cancer cytopathology (2022)
Andrew A Renshaw, Edwin W Gould
Cytology should create structured data sets without using synoptic reporting. Cancer cytopathology 130 (8) (2022)
Andrew A Renshaw
Defining quality in thyroid FNA. Cancer cytopathology 130 (4) (2021)
Andrew A Renshaw
Updating the Papanicolaou Society cytologic criteria for invasive adenocarcinoma in cystic pancreaticobiliary specimens. Cancer cytopathology 129 (8) (2021)
Andrew A Renshaw, Edwin W Gould
Error rates in cytology clinical history are correlated with the number of "clicks" needed to obtain it. Cancer cytopathology (2021)
Anthony V D'Amico, Wanling Xie, Elizabeth McMahon, Marian Loffredo, Shana Medeiros, David Joseph, Jim Denham, Parvesh Kumar, Glenn Bubley, Molly Sullivan, Richard Hellwig, Juan Carlos Vera, Rolf Freter, W Jeffrey Baker, Jeffrey Y Wong, Andrew A Renshaw, Philip W Kantoff
Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Andrew A Renshaw
Should cytologists diagnose clear cell papillary renal cell carcinoma on cytologic material? Cancer cytopathology 129 (3) (2020)
Andrew A Renshaw, Edwin W Gould, Gilles Russ, David N Poller
Thyroid FNA: Is cytopathologist review of ultrasound features useful? Cancer cytopathology 128 (8) (2020)
Andrew A Renshaw, Edwin W Gould
Effusion cytology of epithelioid rhabdomyosarcoma. Diagnostic cytopathology 47 (10) (2019)
Andrew A Renshaw, Edwin W Gould
Risk of death due to disease for thyroid fine-needle aspirations of well-differentiated thyroid carcinomas. Diagnostic cytopathology 47 (10) (2019)
Andrew A Renshaw, Jeffrey F Krane
Communicating risk for thyroid FNA: The pursuit of a better metric. Cancer cytopathology 128 (4) (2019)
Kristine S Wong, Vickie Y Jo, Alarice C Lowe, William C Faquin, Andrew A Renshaw, Akeesha A Shah, Michael H Roh, Edward B Stelow, Jeffrey F Krane
Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study. Cancer cytopathology 128 (1) (2019)
Andrew A Renshaw, Edwin W Gould
Improving the diagnostic accuracy of biliary cytology. Diagnostic cytopathology 47 (7) (2019)
Andrew A Renshaw, Alex Powell, Jorge Caso, Edwin W Gould
Needle track seeding in renal mass biopsies. Cancer cytopathology 127 (6) (2019)
Athena L Chen, Andrew A Renshaw, William C Faquin, Erik K Alexander, Howard T Heller, Edmund S Cibas
Thyroid FNA biopsies comprised of abundant, mature squamous cells can be reported as benign: A cytologic study of 18 patients with clinical correlation. Cancer cytopathology 126 (5) (2018)
Andrew A Renshaw, George G Birdsong
Freeing the data from cytology databases in order to improve the quality of cytology. Diagnostic cytopathology 47 (1) (2018)
Andrew A Renshaw, Edwin W Gould
Evidence-based adequacy criteria for instrumented urine cytology using cytospin preparations. Diagnostic cytopathology 46 (6) (2018)
Susan G R McDuff, Ming-Hui Chen, Andrew A Renshaw, Marian J Loffredo, Philip W Kantoff, Anthony V D'Amico
Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer. Cancer 124 (7) (2018)
Andrew A Renshaw, Edwin W Gould
Fine-needle aspiration of tubulocystic renal cell carcinoma. Diagnostic cytopathology 46 (8) (2018)
Andrew A Renshaw, Edwin W Gould
Predominance of neutrophils in the cerebrospinal fluid of patients treated with intravenous immunoglobulin. Diagnostic cytopathology 46 (3) (2017)
Katelyn M Atkins, Ming-Hui Chen, Jing Wu, Andrew A Renshaw, Marian Loffredo, Philip W Kantoff, Eric J Small, Anthony V D'Amico
Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials. Cancer 124 (7) (2017)
Andrew A Renshaw, Ewing W Gould
Adequate sampling of multiple thyroid nodules by fine-needle aspiration. Cancer cytopathology 125 (11) (2017)
Andrew A Renshaw, Edwin W Gould
High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin. Cancer cytopathology 126 (1) (2017)
Andrew A Renshaw, Edwin W Gould
Incidence and significance of true papillae in thyroid fine needle aspiration. Diagnostic cytopathology 45 (8) (2017)
Marina Vivero, Andrew A Renshaw, Jeffrey F Krane
Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only. Cancer cytopathology 125 (7) (2017)